'Metal debris' might be found inside the engine.
Where, when and how to watch it from the UK.
The company said the 'password era is ending'.
Taipei-based biotech company Jyong Biotech Ltd. has leveraged a successful IPO to accelerate the development of MCS-2, a promising treatment for benign prostatic hyperplasia (BPH).
‘People don't want their homes to be reviewed by anyone from burglars through to stalkers.’
© OfficialAffairs